Clinical Trials Directory

Trials / Conditions / Cutaneous Leishmaniases

Cutaneous Leishmaniases

13 registered clinical trials studyying Cutaneous Leishmaniases — 1 currently recruiting.

StatusTrialSponsorPhase
RecruitingOPTImizing MIltefosine Treatment for Cutaneous LEISHmaniasis Patients
NCT06514560
Institute of Tropical Medicine, Belgium—
UnknownStudy of Cases of Cutaneous Leishmaniasis Treated With Miltefosine in French Guiana, Retrospective Study
NCT05493059
Centre Hospitalier de Cayenne—
CompletedSpatial Analysis of Host-parasite Interactions in Cutaneous Leishmaniasis in Ethiopia
NCT05332093
Institute of Tropical Medicine, Belgium—
CompletedA Clinical Study to Develop a Controlled Human Infection Model Using Leishmania Major-infected Sand Flies
NCT04512742
University of YorkN/A
CompletedCombination, Miltefosine Monotherapy for Cutaneous Leishmaniasis in New World
NCT04515186
Drugs for Neglected DiseasesPhase 3
TerminatedDiagnosis of Cutaneous Leishmaniasis Using the CL-detect Rapid Test in Travelers and Migrants in Belgium
NCT04001335
Institute of Tropical Medicine, Belgium—
CompletedOutcomes of Complicated CL in Ethiopia Treated With Miltefosine
NCT04004754
Institute of Tropical Medicine, Belgium—
CompletedSingle Oral Dose Escalation Study of DNDI-0690 in Healthy Subjects
NCT03929016
Drugs for Neglected DiseasesPhase 1
CompletedCutaneous Leishmaniasis Diagnostic Study
NCT03837431
Institute of Tropical Medicine, Belgium—
TerminatedComplex Cutaneous Leishmaniasis Healing Study in Algeria
NCT03292835
K. W. Stahl—
TerminatedEffectiveness, Safety and Feasibility of HECT-CL, in Quetta, Pakistan
NCT03208543
Medecins Sans Frontieres, NetherlandsPhase 3
CompletedEvaluation of Point-of-care Tests for the Diagnosis of Cutaneous Leishmaniasis in Afghanistan
NCT03435419
Foundation for Innovative New Diagnostics, Switzerland—
CompletedEfficacy and Safety of Pentamidine (7mg/kg) for Patients With Cutaneous Leishmaniasis Caused by L. Guyanensis
NCT02919605
Fundação de Medicina Tropical Dr. Heitor Vieira DouradoPhase 2